All In MedTech

Device Trial Radar · NCT05175885

Ex Vivo Normothermic Perfusion in Kidney Transplantation.

Multicenter, Prospective and Open-label Clinical Trial to Evaluate the Viability, Performance and Safety of ex Vivo Normothermic Perfusion in Kidney Transplantation From DCD and DBD Donors.

Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Dec 14, 2023

Primary completion

Dec 2027

Study completion Dec 2029

Sponsor

Lead sponsor
Ebers Medical Technology, S.L.Not on our public-company list
Sponsor type
Industry
First posted
Jan 4, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A multicenter, prospective and open-label clinical investigation to evaluate the viability, performance and safety of ex vivo normothermic perfusion in kidney transplantation from DCD and DBD donors.

Conditions

  • Kidney Transplantation

Interventions

  • Ex vivo normothermic perfusionDevice

    Ex vivo normothermic perfusion (EVNP) of the renal graft with the Ark Kidney System

  • Cold preservationDevice

    Static cold storage (SCS) or hypothermic machine perfusion (HMP) of the renal graft

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of EVNP in kidney transplantation from DCD and DBD donors as evaluated by assessment of adverse eventsTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Miguel Servet University Hospital

    Zaragoza, Zaragoza, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.